RXRA
MOLECULAR TARGETretinoid X receptor alpha
RXRA (retinoid X receptor alpha) is targeted by 53 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting RXRA
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 53 compounds. Use the BiohacksAI search to explore all RXRA modulators.
About RXRA as a Drug Target
RXRA (retinoid X receptor alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 53 compounds with documented RXRA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
RXRA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.